Suppr超能文献

癌症临床试验信息寻求的差异:美国国家癌症研究所癌症信息服务的发现。

Disparities in cancer clinical trials information-seeking: Findings from the National Cancer Institute's Cancer Information Service.

机构信息

National Cancer Institute, Behavioral Research Program, Division of Cancer Control and Population Sciences, 9609 Medical Center Dr, Rockville, MD, USA.

Westat, 1600 Research Blvd, Rockville, MD, USA.

出版信息

Patient Educ Couns. 2024 Oct;127:108358. doi: 10.1016/j.pec.2024.108358. Epub 2024 Jun 24.

Abstract

OBJECTIVE

To better understand cancer clinical trials (CCT) information-seeking, a necessary precursor to patient and provider engagement with CCT.

METHODS

Data from the National Cancer Institute's Cancer Information Service (CIS) were used to examine CCT information-seeking patterns over a 5-year period. Descriptive and logistic regression analyses were conducted to examine characteristics of CIS inquiries and their associations with having a CCT discussion.

RESULTS

Between September 2018 - August 2023, 117,016 CIS inquiries originated from cancer survivors, caregivers, health professionals, and the general public; 27.5 % of these inquiries included a CCT discussion (n = 32,160). Among CCT discussions, 35.5 % originated from survivors, 53.5 % from caregivers, 6.1 % from the public, and 4.9 % from health professionals. Inquiries in Spanish had lower odds of a CCT discussion (OR=.26, [.25-.28]), whereas inquiries emanating from the CIS instant messaging (OR=2.29, [2.22-2.37]) and email (OR=1.24, [1.18-1.30]) platforms were associated with higher odds of discussing CCT compared to the telephone. Individuals who were male, younger, insured, and had higher income and education had significantly higher odds of a CCT discussion while those who were non-Hispanic Black and living in rural locales had significantly lower odds.

CONCLUSIONS

Disparities in CCT information-seeking may contribute to downstream CCT participation.

PRACTICE IMPLICATIONS

Quality, language-concordant health information is needed to enable equitable awareness of - and ultimately engagement in - CCT.

摘要

目的

为了更好地了解癌症临床试验(CCT)信息搜索,这是患者和提供者参与 CCT 的必要前提。

方法

利用美国国立癌症研究所癌症信息服务(CIS)的数据,在 5 年内研究 CIS 咨询的 CCT 信息搜索模式。采用描述性和逻辑回归分析,研究 CIS 查询的特征及其与 CCT 讨论的关系。

结果

2018 年 9 月至 2023 年 8 月期间,CIS 共收到 117016 条来自癌症幸存者、护理人员、卫生专业人员和公众的查询,其中 27.5%的查询涉及 CCT 讨论(n=32160)。在 CCT 讨论中,35.5%来自幸存者,53.5%来自护理人员,6.1%来自公众,4.9%来自卫生专业人员。西班牙语查询的 CCT 讨论可能性较低(OR=0.26,[0.25-0.28]),而 CIS 即时通讯(OR=2.29,[2.22-2.37])和电子邮件(OR=1.24,[1.18-1.30])平台的查询则与更高的 CCT 讨论可能性相关。男性、年轻、有保险、收入和教育程度较高的个体讨论 CCT 的可能性显著更高,而非西班牙裔黑人以及居住在农村地区的个体则显著更低。

结论

CCT 信息搜索的差异可能导致下游 CCT 参与的差异。

实践意义

需要提供高质量、语言一致的健康信息,以实现对 CCT 的公平认知,并最终参与其中。

相似文献

1
Disparities in cancer clinical trials information-seeking: Findings from the National Cancer Institute's Cancer Information Service.
Patient Educ Couns. 2024 Oct;127:108358. doi: 10.1016/j.pec.2024.108358. Epub 2024 Jun 24.
3
Childhood Cancer Information-Seeking: Findings from the National Cancer Institute's Cancer Information Service.
J Cancer Educ. 2023 Jun;38(3):1084-1090. doi: 10.1007/s13187-022-02237-w. Epub 2022 Nov 22.
4
Understanding Cannabis-Related Information Needs: An Analysis of Inquiries to the National Cancer Institute's Cancer Information Service.
Cannabis Cannabinoid Res. 2024 Oct;9(5):e1452-e1458. doi: 10.1089/can.2023.0119. Epub 2023 Oct 19.
6
Discussions of cancer clinical trials with the National Cancer Institute's Cancer Information Service.
J Health Commun. 2012;17(3):319-37. doi: 10.1080/10810730.2011.626500. Epub 2011 Dec 12.
7
Cancer Information-seeking in an Age of COVID-19: Findings from the National Cancer Institute's Cancer Information Service.
Health Commun. 2021 Jan;36(1):89-97. doi: 10.1080/10410236.2020.1847449. Epub 2020 Nov 22.
8
Barriers to seeking cancer information among Spanish-speaking cancer survivors.
J Cancer Educ. 2009;24(3):167-71. doi: 10.1080/08858190902873053.

引用本文的文献

本文引用的文献

1
Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020.
J Natl Cancer Inst. 2024 Jul 1;116(7):1063-1071. doi: 10.1093/jnci/djae018.
3
Survivorship science at the National Institutes of Health 2017-2021.
J Cancer Surviv. 2024 Oct;18(5):1443-1452. doi: 10.1007/s11764-023-01414-0. Epub 2023 Jun 10.
4
"There's not enough studies": Views of black breast and ovarian cancer patients on research participation.
Cancer Med. 2023 Apr;12(7):8767-8776. doi: 10.1002/cam4.5622. Epub 2023 Jan 16.
6
Diversity of Participation in Clinical Trials and Influencing Factors: Findings from the Health Information National Trends Survey 2020.
J Gen Intern Med. 2023 Mar;38(4):961-969. doi: 10.1007/s11606-022-07780-2. Epub 2022 Sep 22.
7
African American Perceptions of Participating in Health Research Despite Historical Mistrust.
ANS Adv Nurs Sci. 2023;46(1):41-58. doi: 10.1097/ANS.0000000000000435. Epub 2022 Aug 19.
8
Strategies to Advance Equity in Cancer Clinical Trials.
Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-11. doi: 10.1200/EDBK_350565.
9
A Scoping Review of Strategies to Increase Black Enrollment and Retention in Cancer Clinical Trials.
JCO Oncol Pract. 2022 Sep;18(9):614-632. doi: 10.1200/OP.21.00863. Epub 2022 Jun 7.
10
Online Medical Misinformation in Cancer: Distinguishing Fact From Fiction.
JCO Oncol Pract. 2022 Aug;18(8):584-589. doi: 10.1200/OP.21.00764. Epub 2022 Mar 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验